O

Odimma Therapeutics

8 employees

Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
DeepTech
Health Care
Cancer Immunotherapy
Therapeutics
Research & Development
Personalized Medicine
Onco-Immunology
Life Science

Date founded

2017

Funding rounds raised

Total raised

$2M

from 2 investors over 2 rounds

O

Odimma Therapeutics raised $2M on April 13, 2023

Investors: Angels Santé and Alsace Business Angels

FAQ